Young Investigator Award

Emilie LAU

International Digestive Disease Forum is Asia Pacific’s hub of gastroenterology and hepatology related knowledge exchange. One main appeal of the forum, the Young Investigator Award, provides a platform specifically for young investigators to share their research and thereby gain recognition. All participants submit an abstract which is scored by the local scientific committee. Authors of the abstracts with the highest scores in both gastroenterology and hepatology will present their works at the Young Investigator Award session. A panel of adjudicators composed of three eminent international experts will provide critical feedback to the presenters. The presentations are ranked according to the importance of the research question, strength of research methodology, quality of results, clarity of the presentation and scientific impact of the research. One winner and two runners-up will receive an award presented by the chief adjudicator at the opening ceremony of the forum.



7KC_8080 copy.jpg 







Wonseok Kang – Korea

HCV Activates Protein Kinase R and Attenuates Interferon-Induced MHC Class I Expression to Circumvent Cd8+ T-Cell Responses




Yao-Chun Hsu – Taiwan

Antiviral Treatment and Risk of End-Stage Renal Disease in Patients with Hepatitis C Virus Infection: A Nationwide Total Population Study




Nir Salomon –  Israel

Berberine, Alone and In Conjunction with Immuno-Modulators, Down-Regulates Pro-Inflammatory Cd4+T-Cells: Implications for a Combined Treatment of Inflammatory Bowel Diseases








Xiaolong Qi – China

Virtual Portal Venous Pressure from Anatomic CT Angiography





Seung Up Kim – South Korea

Histological Sub-Classification of Cirrhosis is Useful for Predicting Recurrence and Survival After Curative Resection of HBV-Related Hepatocellular Carcinoma





Yanna Ko – Australia

Inflammatory Bowel Disease Environmental Risk Factors: A Case-Control Study of The Middle Eastern Migrant Population








Chung Feng Huang – Taiwan


Profound Week 4 Response to Peginterferon/Ribavirin is Mandatory for Hepatitis C Genotype Patients with Unfavorable Il-28b Genotype





Lucy Lim – Australia


Tenofovir Disoproxil Fumarate Rescue Therapy Following Multi-Drug Resistant Chronic Hepatitis B





Chieh Chang Chen – Taiwan


The Efficacy of Genotypic Resistance-Guided Sequential Therapy in The Refractory Helicobacter Pylori Infection- A Multicenter Clinical Trial